State of New Jersey Common Pension Fund D’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.66M Sell
14,519
-1,793
-11% -$154K 0.01% 1189
2026
Q1
$1.36M Sell
16,312
-17,226
-51% -$1.36M 0.01% 1381
2025
Q4
$2.61M Buy
+33,538
New +$2.26M 0.01% 845

Other funds holding KYMR

State of New Jersey Common Pension Fund D's KYMR Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Kymera Therapeutics (KYMR) stake by 11% in Q2 2026, selling an estimated $154K and leaving 14,519 shares worth $1.66M. The position accounts for 0.01% of the portfolio, ranked #1189.

State of New Jersey Common Pension Fund D first reported a position in KYMR in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.61M in Q4 2025. 93 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 14,519 shares of Kymera Therapeutics worth $1.66M as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 1,793 Kymera Therapeutics shares in Q2 2026, an estimated $154K.
  • Kymera Therapeutics made up 0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1189 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Kymera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • State of New Jersey Common Pension Fund D's Kymera Therapeutics position peaked at $2.61M in Q4 2025.
  • 93 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.